HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

optivate

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Baglin, T: 3 articles (05/2011 - 03/2011)
2.	Dmoszynska, A: 3 articles (05/2011 - 03/2011)
3.	Hellmann, A: 3 articles (05/2011 - 03/2011)
4.	Makris, M: 3 articles (05/2011 - 03/2011)
5.	Shaikh-Zaidi, R: 3 articles (05/2011 - 03/2011)
6.	Dash, C: 2 articles (05/2011 - 03/2011)
7.	Gascoigne, E: 2 articles (05/2011 - 03/2011)
8.	Hay, C: 2 articles (05/2011 - 03/2011)
9.	Kloczko, J: 2 articles (05/2011 - 03/2011)
10.	Kuliczkowski, K: 2 articles (05/2011 - 03/2011)

Related Diseases

1.

Hemophilia A (Haemophilia)

03/01/2011 - "Therefore, the PK of FVIII is not affected by the processes used to manufacture Optivate(®), which can be expected to be effective in the management of patients with haemophilia A."
05/01/2011 - "The studies confirm the clinical efficacy and safety of Optivate(®) in both prophylactic and on-demand management of patients with haemophilia A."
05/01/2011 - "The efficacy and safety of Optivate(®) was assessed in 23 surgical operations, orthopaedic (12) including 5 revision arthroplasties, ophthalmic (1), ENT (1), dental (6), liver biopsy (2), and removal of portacath (1) on 15 teenagers and adults with severe haemophilia A. "
03/01/2011 - "Pharmacokinetics of Optivate(®), a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A."

Related Drugs and Biologics

1.	von Willebrand Factor
2.	Factor VIII (Coagulation Factor VIII)

Related Therapies and Procedures

1.	Vascular Access Devices (Arterial Line)
2.	Arthroplasty